My Cart

CD46

CD46 Overview

English NameMembrane cofactor proteinApproved Drugs0
Drugs in Clinical Trials5Target SynonymTLX,MCP,CD46,CD46 Molecule,Membrane Cofactor Protein (CD46, Trophoblast-Lymphocyte Cross-Reactive Antigen),Antigen Identified By Monoclonal Antibody TRA-2-10,CD46 Molecule, Complement Regulatory Protein,CD46 Antigen, Complement Regulatory Protein,Trophoblast Leukocyte Common Antigen,MIC10,Trophoblast-Lymphocyte Cross-Reactive Antigen,Complement Membrane Cofactor Protein,Trophoblast Leucocyte Common Antigen,Measles Virus Receptor,CD46 Antigen,TRA2.10,AHUS2,Membrane cofactor protein,MGC26544
Highest Development StagePhase 2 Clinical
English NameMembrane cofactor protein
Target SynonymTLX,MCP,CD46,CD46 Molecule,Membrane Cofactor Protein (CD46, Trophoblast-Lymphocyte Cross-Reactive Antigen),Antigen Identified By Monoclonal Antibody TRA-2-10,CD46 Molecule, Complement Regulatory Protein,CD46 Antigen, Complement Regulatory Protein,Trophoblast Leukocyte Common Antigen,MIC10,Trophoblast-Lymphocyte Cross-Reactive Antigen,Complement Membrane Cofactor Protein,Trophoblast Leucocyte Common Antigen,Measles Virus Receptor,CD46 Antigen,TRA2.10,AHUS2,Membrane cofactor protein,MGC26544
Approved Drugs0
Drugs in Clinical Trials5
Highest Development StagePhase 2 Clinical

CD46 Product List

  • Product Category

    Protein (5)

  • Product Status

    Launched (5)

  • Species

    Human (5)

  • Tag

    His Tag (4)Fc Tag (1)

  • Conjugate

    Unconjugated (2)FITC Labeled (1)APC Labeled (1)PE Labeled (1)

CD46 Background

Complement regulatory protein CD46 is also known as membrane Cofactor Protein (MCP), is a type I membrane protein and is a regulatory part of the complement system. CD46 is expressed by all cells except erythrocytes. MCP acts as a cofactor for complement factor I, a serine protease which protects autologous cells against complement-mediated injury by cleaving C3b and C4b deposited on host tissue, and also acts as a costimulatory factor for T-cells which induces the differentiation of CD4+ into T-regulatory 1 cells. In T-cells by binding to CD46, A number of viral and bacterial pathogens seem to exploit this property and directly induce an immunosuppressive phenotype. Defects in CD46 are a cause of susceptibility to hemolytic uremic syndrome atypical type 2 (AHUS2).

CD46 Synonyms

CD46,AHUS2,MCP,MIC10,TLX,TRA2.10

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Anti-CD46 antibody drug conjugate (Fortis Therapeutics)FG-3246; FOR-46Phase 2 ClinicalUniversity Of California San DiegoMultiple Myeloma; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
EnadenotucirevColoAd-1; Oncolytic Ad11/Ad3Phase 1 ClinicalAkamis Bio LtdCarcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms
Details
AugmAbBRM-132Phase 1 ClinicalCompliment CorpLymphoma, Non-Hodgkin; Neoplasms
Details
YS-5YS-5Phase 1 ClinicalFortis Therapeutics Inc, United States Department Of DefenseProstatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
FG-318089Zr-DFO-YS-5; 89Zr-DFO-YS5Phase 1 ClinicalFortis Therapeutics IncMultiple Myeloma; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland